![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Chronic Heart Failure |
Free Subscription
1 Am Heart J |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Chronic Heart Failure is free of charge.
Effects of COVID-19 on Heart Failure Admissions.
Am Heart J. 2023 May 6:S0002-8703(23)00111-4. doi: 10.1016/j.ahj.2023.
PubMed
Abstract available
Atrial Fibrillation and Heart Failure: Is It the Chicken or the Egg?
Am J Cardiol. 2023 May 5:S0002-9149(23)00209.
PubMed
Association of Nondihydropyridine Calcium Channel Blockers Versus beta-Adrenergic
Receptor Blockers With Risk of Heart Failure Hospitalization.
Am J Cardiol. 2023 May 5:S0002-9149(23)00211.
PubMed
Abstract available
Residing in a Food Desert and Adverse Cardiovascular Events in US Veterans With
Established Cardiovascular Disease.
Am J Cardiol. 2023;196:70-76.
PubMed
Abstract available
Characteristics of Right Ventricular to Pulmonary Arterial Coupling and
Association With Functional Status Among Older Aged Adults from the Multi-Ethnic
Study of Atherosclerosis.
Am J Cardiol. 2023;196:41-51.
PubMed
Abstract available
Corrigendum to: Reduced lean body mass: a potential modifiable contributor to the
pathophysiology of heart failure.
Eur Heart J. 2023 May 8:ehad272. doi: 10.1093.
PubMed
Circulating ketone bodies and cardiovascular outcomes: the MESA study.
Eur Heart J. 2023 Mar 6:ehad087. doi: 10.1093.
PubMed
Abstract available
Systems of care for heart failure: bridging the divide between primary care and
specialist services.
Heart. 2023 May 5:heartjnl-2022-321757. doi: 10.1136/heartjnl-2022-321757.
PubMed
Hypotension at heart failure discharge: Should it be a limiting factor for drug
titration?
Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
PubMed
Abstract available
Influence of exertional oscillatory breathing and its temporal behavior in
patients with heart failure and reduced ejection fraction.
Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
PubMed
Abstract available
SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease:
Jigsaw Falling Into Place.
J Am Coll Cardiol. 2023;81:1915-1917.
PubMed
Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney
Risk Categories.
J Am Coll Cardiol. 2023;81:1902-1914.
PubMed
Abstract available
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With
Preserved Ejection Fraction in Japan.
J Card Fail. 2023;29:375-388.
PubMed
Abstract available
TRAIL or TRAIL-R2 as a predictive biomarker for mortality or cardiovascular
events: A systematic review and meta-analysis.
J Cardiovasc Pharmacol. 2023 Mar 9. doi: 10.1097/FJC.0000000000001415.
PubMed
Abstract available
Patient perspectives on the use of mobile apps to support heart failure
management: A qualitative descriptive study.
PLoS One. 2023;18:e0285659.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by